Institutes for Systems Genetics, West China Hospital
Copyright @ 2023 ISG. All Rights Reserved.
Group name
Intermediate-risk
Groups definition
intermediate-risk defined as having at least one characteristic among clinical stage T2b-c or GS of 7 or PSA level of 10 to 20 ng/mL and 95 patients were classified as high-risk defined as having at least one characteristic among clinical stage ≥ T3a or GS ≥8 or PSA level ≥20 ng/mL according to the National Comprehensive Cancer Network (NCCN) classification
Age
66 (62–69)
PSA
6.4 (5.0-8.6)
No of total biopsy cores, median (IQR)
20 (14-20)
No of positive cores, median (IQR)
3 (2-5)
Institutes for Systems Genetics, West China Hospital
Copyright @ 2023 ISG. All Rights Reserved.